A phase II study of bortezomib in patients with relapsed or refractory aggressive adult T-cell leukemia/lymphoma

Adult T-cell leukemia/lymphoma (ATL) is a malignancy of peripheral T-lymphocytes with a poor prognosis. This multicenter, two-stage, single-arm, phase II study assessed the efficacy and safety of bortezomib in patients with relapsed/refractory ATL who received at least one regimen of chemotherapy. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishitsuka, Kenji, Utsunomiya, Atae, Katsuya, Hiroo, Takeuchi, Shogo, Takatsuka, Yoshifusa, Hidaka, Michihiro, Sakai, Tatsunori, Yoshimitsu, Makoto, Ishida, Takashi, Tamura, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582992/
https://www.ncbi.nlm.nih.gov/pubmed/26179770
http://dx.doi.org/10.1111/cas.12735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582992/
https://www.ncbi.nlm.nih.gov/pubmed/26179770
http://dx.doi.org/10.1111/cas.12735

Ejemplares similares